AstraZeneca (AZN) Health Care Sector

  • Latest quote

    6,427.00p (mid)

  • Current Change (%)

    0.80%

  • Price

    Bid: 6,426.00p

    Offer: 6,427.00p

  • Today

    High: 6,444.00p

    Low: 6,344.00p

  • This year

    High: 6,525.00p

    Low: 4,760.00p

  • Information

    Volume: 842,775

    Market Cap: £81430.09M



AstraZeneca Overview

A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.

AstraZeneca RNS Feed

Title Release date
Forxiga approved in Europe for type-1 diabetes 07:00 - March 25, 2019
US FDA grants saracatinib ODD for IPF 07:00 - March 18, 2019
Notice of AGM 12:00 - March 14, 2019
Director/PDMR Shareholding 12:00 - March 12, 2019
Filing of Form 20-F with SEC 07:00 - March 6, 2019
Annual Financial Report 11:00 - March 5, 2019
Holding(s) in Company 16:04 - March 4, 2019
Total Voting Rights 15:00 - March 1, 2019
Lynparza receives positive EU CHMP opinion 13:45 - March 1, 2019
Lynparza significantly delayed disease progression 07:00 - February 26, 2019
Brilinta's PhIII THEMIS trial met primary endpoint 07:00 - February 25, 2019
AstraZeneca Full-Year and Q4 2018 Results 07:00 - February 14, 2019
US FDA grants Fasenra Orphan Drug Designation 07:00 - February 6, 2019
US FDA grants Breakthrough Therapy Designation 07:05 - February 5, 2019
EMA grants PRIME eligibility for MEDI8897 07:00 - February 5, 2019

NOTE: This is based on 204 open tips for this company


Total Number of Share tips :

431

View all AstraZeneca Tips



Daily share tips delivered straight to your pc, tablet & mobile

Join Free Today